Press Releases and Media
Recent Press Releases
10/27/2011: BIND Announces New $47.25 Million Financing To Accelerate Multi-Product Pipeline
10/27/2011: RUSNANO invests in BIND Biosciences
04/06/2011: BIND Biosciences Receives 2011 Edison Award
02/23/2011: BIND Biosciences named one of MIT's Technology Review 2011 TR50 - second year in a row
02/11/2011: BIND Biosciences featured in the London Times
01/24/2011: BIND Biosciences featured in Chemistry and Industry
01/07/2011: BIND Biosciences Initiates Phase 1 Clinical Study of BIND-014
12/12/2010: BIND Biosciences Published on Nanoparticles in Nature Biotechnology
07/19/2010: BIND Biosciences featured in Genetic Engineering and Biotechnology news
06/29/2010: BIND Biosciences Secures $12.4 Million Financing
06/28/2010: BIND Biosciences Appoints Ed Schnipper, M.D., as Chief Medical Officer
01/25/2010: BIND Biosciences and Scott Minick featured in FierceBiotech
01/14/2010: BIND Biosciences featured in Bioworld Today
01/14/2010: BIND Biosciences, Inc. Closes $11M Series C financing round
01/11/2010: BIND Biosciences Appoints Scott Minick as President and CEO
11/04/2009: BIND Biosciences development and manufacturing capabilities featured in MIT Technology Review
10/29/2009: BIND Biosciences co-founder selected as 2009 Mass High Tech All-Star
Recent Media
BIND banks $12.4M round as lead program
heads into PI (Fierce Biotech, June 2010)
Former J&J Group Chairman's Firm
Backs BIND Biosciences in $12.4M Round (Xconomy, June, 2010)
Nanoparticle cancer
therapy targets tumours and dodges immune system (London Times on Line, November 2009)
Stealthy Nanoparticles Attack Cancer Cells (Technology Review, November 2009)
BIND Biosciences: Emerging company profile (BioCentury, July 2008)
Where Investor Meets Scientist (Wall Street Journal, April 2008)
Bioworld article on BIND Biosciences (Bioworld, November 2007)
|
